Endometrial cancer (EC) is the most common gynecologic malignancy in the United States and in many other developed countries. Women with EC detected at an early stage have a higher likelihood of being cured of their cancer. A recent study by Mayo Clinic researchers, published in Gynecologic Oncology, aims to demonstrate the feasibility of detecting EC by combining minimally invasive specimen collection techniques with sensitive molecular testing.
Refining Individualized Medicine: Study Reduces Time to Deliver Treatment Plan for Melanoma Patients
With the emergence of individualized medicine—treating a person as an individual and tailoring health care specific to that patient—developments in precision diagnostics are a critical driving force, especially via molecular testing. A recent study by Mayo Clinic researchers, published in the journal Human Pathology, aims to design and implement a scalable process that permits pre-appointment BRAF/KIT mutation analysis in melanoma patients.
The National Comprehensive Cancer Network (NCCN) and American Urological Association (AUA) provide guidelines for surveillance after surgery for renal cell carcinoma (RCC). In a recent study in the Journal of Clinical Oncology, Mayo Clinic researchers assess the ability of the guidelines to capture RCC recurrences after surgery when abiding by the prescribed protocols.
Renal Cell Carcinoma (RCC) with Rhabdoid Differentiation
Predicting Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
Study Finds Decipher Prostate Cancer Test Predicts which Patients Benefit from Radiation Therapy
Patient Outcome with Micropapillary Urothelial Carcinoma Following Cadical Cystectomy
- A Test in Focus
RAS/RAF Targeted Gene Panel by Next Generation Sequencing, Tumor